參考文獻/References:
[1] MACEDO F,LADEIRA K,PINHO F,et al.Bone metastases:an overview[J].Oncol Rev,2017,11(1):321.
[2] CENGIZ A,G?KSEL S,Y?REKLI Y.Diagnostic value of 18F-FDG PET/CT in patients with carcinoma of unknown primary[J].Mol Imaging Radionucl Ther,2018,27(3):126-132.
[3] BUDAK E,YANARATE?�瘙?塁? A.Role of(18)F-FDG PET/CT in the detection of primary malignancy in patients with bone metastasis of unknown origin[J].Rev Esp Med Nucl Imagen Mol,2020,39(1):14-19.
[4] BURGLIN SA,HESS S,H?ILUND-CARLSEN PF,et al.18F-FDG PET/CT for detection of the primary tumor in adults with extracervical metastases from cancer of unknown primary:a systematic review and meta-analysis[J].Medicine(Baltimore),2017,96(16):e6713.
[5] 朱艷芳,謝新立,于艷霞,等.18F-FDG PET/CT顯像SUVmax對不同病理分型腎細胞癌的鑒別價值[J].鄭州大學學報(醫(yī)學版),2018,53(6):807-811.
[6] RIAZ S,NAWAZ M K,FARUQUI Z S,et al.Diagnostic accuracy of 18F-Fluorodeoxyglucose positron emission tomography-computed tomography in the evaluation of carcinoma of unknown primary[J].Mol Imaging Radionucl Ther,2016,25(1):11-18.
[7] TAMAM C,TAMAM M,MULAZIMOGLU M.The accuracy of 18F-Fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of bone lesions of undetermined origin[J].World J Nucl Med,2016,15(2):124-129.
[8] TAKAGI T,KATAGIRI H,KIM Y,et al.Skeletal metastasis of unknown primary origin at the initial visit:a retrospective analysis of 286 cases[J].PLoS One,2015,10(6):e0129428.
[9] KWEE T C,BASU S,ALAVI A.PET and PET/CT for unknown primary tumors[J].Methods Mol Biol,2011,727:317-333.
[10] 齊紅艷,孫遜,安銳.骨轉移瘤影像學檢查方法及相關進展[J].華中科技大學學報(醫(yī)學版),2015(1):121-124.
[11] 倪世家.骨轉移瘤18F-FDG PET/CT SUVmax與其大小及組織學類型的相關性研究[D].大連:大連醫(yī)科大學,2018.
[12] 李遠,牛曉輝,徐海榮.18F-FDG PET/CT顯像在骨轉移癌診斷中的應用[J].山東醫(yī)藥,2011,51(40):14-16.
[13] YUN M J.Imaging of gastric cancer metabolism using 18F-FDG PET/CT[J].J Gastric Cancer,2014,14(1):1-6.
[14] SON G M,KIM S J.Diagnostic accuracy of F-18 FDG PET/CT for characterization of colorectal focal FDG uptake:a systematic review and meta-analysis[J].Abdom Radiol(NY),2019,44(2):456-463.
[15] WU D,HU Y,WEI Q,et al.Three primary carcinomas on 18F-FDG PET/CT:intrahepatic cholangiocarcinoma,papillary renal cell carcinoma,and clear cell renal cell carcinoma[J].Clin Nucl Med,2018,43(6):428-430.
[16] PARK S B,PARK J M,MOON S H,et al.Role of 18F-FDG PET/CT in patients without known primary malignancy with skeletal lesions suspicious for cancer metastasis[J].PLoS One,2018,13(5):e0196808.
[17] 陳菩蕓,王雪鵑,楊志.18F-FDG PET/CT顯像對可疑甲狀腺原發(fā)病變的評估價值[J].標記免疫分析與臨床,2014,21(1):45-49.
[18] 董孟杰,林祥通,趙軍,等.17例惡性腫瘤18氟脫氧葡萄糖PET顯像假陰性的分析[J].中華腫瘤雜志,2006,28(9):713-717.
[19] FRAUM T J,LUDWIG D R,KIM E H,et al.Prostate cancer PET tracers:essentials for the urologist[J].Can J Urol,2018,25(4):9371-9383.
[20] SHARMA A,METE U K,SOOD A,et al.Utility of early dynamic and delayed post-diuretic(18)F-FDG PET/CT SUV(max)in predicting tumour grade and T-stage of urinary bladder carcinoma:results from a prospective single centre study[J].Br J Radiol,2017,90(172):20160787.